Mode
Text Size
Log in / Sign up

Euthanasia and assisted suicide for mental disorders: variability in legal models and clinical approaches

Euthanasia and assisted suicide for mental disorders: variability in legal models and clinical…
Photo by Md Mahdi / Unsplash
Key Takeaway
Recognize the variability in EAS approaches for mental disorders and the need for standardized criteria and multidisciplinary evaluation.

This narrative review synthesizes the literature on euthanasia and assisted suicide (EAS) for patients with mental disorders, focusing on decision-making capacity, irremediability of suffering, subjective suffering and voluntariness, safeguard systems, and assessment processes. The authors report that considerable variability exists in legal models and clinical approaches across these domains. A shared emphasis on repeated, multidisciplinary, and well-documented evaluation processes is noted, which may enhance consistency and ethical sustainability. However, the review identifies several limitations, including the absence of standardized criteria for irremediability, inter-rater variability in capacity assessment, and the difficulty of distinguishing between psychopathology-related suicidality and well-considered requests for assisted death. The authors acknowledge that uncertainties cannot be fully resolved. Practice relevance: Multidisciplinary approaches involving clinical psychiatry, forensic psychiatry, and legal medicine may improve consistency, transparency, and medico-legal robustness. Longitudinal assessment and detailed reconstruction of clinical history appear key to supporting reliable decision-making.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BackgroundEuthanasia and assisted suicide (EAS) in individuals with mental disorders represents a complex and controversial area at the intersection of clinical practice, bioethics, and medico-legal evaluation. While suffering is inherently subjective in both psychiatric and somatic conditions, psychiatric contexts are characterized by greater fluctuation, contextual dependence, and prognostic uncertainty, which complicate the assessment of its severity, persistence, and potential reversibility in medico-legal evaluations.MethodsA structured narrative review of the international literature was conducted, focusing on clinical, ethical, and medico-legal aspects of EAS in psychiatric contexts. Regulatory frameworks and empirical contributions were analyzed to identify key domains and areas of ongoing debate.ResultsFive interconnected domains emerge as central to psychiatric EAS assessment: decision-making capacity, irremediability of suffering, subjective suffering and voluntariness, and safeguard systems. Across jurisdictions, considerable variability exists in legal models and clinical approaches, although a shared emphasis on repeated, multidisciplinary, and well-documented evaluation processes is evident. Persistent challenges include the absence of standardized criteria for irremediability, inter-rater variability in capacity assessment, and the difficulty of distinguishing between psychopathology-related suicidality and well-considered requests for assisted death.DiscussionThe available literature suggests that psychiatric EAS requires particularly careful and structured evaluation processes, given the inherent complexity and variability of mental disorders. Multidisciplinary approaches involving clinical psychiatry, forensic psychiatry, and legal medicine may contribute to improving consistency, transparency, and medico-legal robustness. Longitudinal assessment and detailed reconstruction of clinical history appear to be key elements in supporting reliable decision-making.ConclusionsPsychiatric EAS remains an evolving and methodologically challenging topic. While uncertainties cannot be fully resolved, structured and multidisciplinary evaluation processes may help enhance the consistency and ethical sustainability of assessments in this context.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.